VentriFlo

VentriFlo is a private U.S. medical device company developing the VentriFlo True Pulse Pump, a pulsatile blood pumping system intended to better mimic physiologic cardiac output than conventional continuous-flow extracorporeal pumps. The company is focused on pediatric and adult patients who require cardiopulmonary support during surgery or in the ICU, including cardiopulmonary bypass and related extracorporeal applications. Its system combines a single-use pump consumable, an electromagnetic pump driver, and a control console designed to generate biomimetic pulse waveforms. VentriFlo emphasizes potential improvements in microcirculation, organ perfusion, safety, and hospital cost of care. As of 2026, the product remains in development, with preclinical studies reported and no commercial product on the market.